P14.25 18F-fluordesoxyglucose positron emission tomography (FDG-PET/CT) the detection of the primary lesion and staging in brain metastasis (BM) patients with cancer of unknown primary site (CUPS)

Background: In 30% of patients with brain metastasis (BM), BM are the first clinical manifestation of systemic malignancy, referred to as BM from cancer of unknown primary site (BM-CUPS). The value of (18)F-fluordesoxyglucose positron emission tomography (FDG-PET)/CT in the work-up of BM-CUPS patien...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neuro Oncol
Main Authors: Wolpert, F., Le Rhun, E., Berghoff, A., Rushing, E., Andratschke, N., Regli, L., Reyns, N., Kaufmann, P., Preusser, M., Weller, M.
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2017
Teme:
POSTER PRESENTATIONS
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5464281/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.410
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki